This article appeared in the May 2018 issue of ASBMT eNews. Download the full issue in PDF format here.
Register today for the 4th International Workshop on Biology, Prevention and Treatment of Relapse after HSCT. Relapse and disease progression are the leading causes of treatment failure for most hematologic malignancies treated with both allogeneic and autologous hematopoietic stem cell transplantation (HSCT). The planned objectives of the workshop are designed to present the latest scientific and clinical advances related to relapse after HSCT and to provide a forum for the presentation of ongoing laboratory, translational and clinical research specifically related to this field. The educational content of this conference is relevant for medical and pediatric hematologists-oncologists, hematopoietic stem and immune cell translational and basic scientists, hematopathologists, physicians-in-training (Fellows/Residents/Post Docs), advance practice providers, pharmacists, oncology nurses and other associated allied health professionals. The workshop will feature internationally recognized speakers from a multidisciplinary, diverse group composed of basic and translational scientists and clinical investigators.
The Organizing Committee has been working hard to make the Fourth International Workshop a truly valuable experience for all participants. We look forward to welcoming you to the beautiful city of Chicago.
Where: Intercontinental Magnificent Mile, Chicago
When: September 21-22
More Info: www.relapse-after-hsct.com
Call for Abstracts
Relapse After HSCT 2018 is calling for abstracts on all topics related to relapse after HSCT.
Abstract deadline is July 1, and the best abstracts will be chosen for oral presentations.